---
title: "China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281702688.md"
description: "China Renaissance has reaffirmed its Buy rating for Ping An Healthcare and Technology Company (PANHF), setting a price target of HK$23.88. The overall analyst consensus for the company is a Strong Buy, with an average price target of HK$17.63."
datetime: "2026-04-05T05:45:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281702688.md)
  - [en](https://longbridge.com/en/news/281702688.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281702688.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281702688.md) | [繁體中文](https://longbridge.com/zh-HK/news/281702688.md)


# China Renaissance Sticks to Its Buy Rating for Ping An Healthcare and Technology Company (PANHF)

In a report released yesterday, from China Renaissance maintained a Buy rating on Ping An Healthcare and Technology Company, with a price target of HK$23.88.

### End of Quarter Sale - 50% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ping An Healthcare and Technology Company with a HK$17.63 average price target.

### Related Stocks

- [PA GOODDOCTOR (01833.HK)](https://longbridge.com/en/quote/01833.HK.md)

## Related News & Research

- [Jefferies Reaffirms Their Hold Rating on Ping An Healthcare and Technology Company (PANHF)](https://longbridge.com/en/news/280867231.md)
- [Baiyunshan Pharma Gets Approval for Carbocisteine Oral Solution's Registration in Macau](https://longbridge.com/en/news/281478355.md)
- [JD Logistics Grants New Employee Share Awards with Robust Clawback Terms](https://longbridge.com/en/news/281373299.md)
- [11:01 ETPureHealth Research Liver Health Supplements Target Fatty Liver for Improved Daily Energy](https://longbridge.com/en/news/281689012.md)
- [North Mining Shares posts FY profit attributable from continuing operations of HK$243.5 million](https://longbridge.com/en/news/281276392.md)